0001104659-17-041467.txt : 20170727 0001104659-17-041467.hdr.sgml : 20170727 20170626124948 ACCESSION NUMBER: 0001104659-17-041467 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170626 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dova Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001685071 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813858961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2530 MERIDIAN PARKWAY STREET 2: SUITE 300 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-806-4487 MAIL ADDRESS: STREET 1: 2530 MERIDIAN PARKWAY STREET 2: SUITE 300 CITY: DURHAM STATE: NC ZIP: 27713 CORRESP 1 filename1.htm

 

J.P. Morgan Securities LLC

383 Madison Avenue

New York, New York 10179

 

Jefferies LLC

520 Madison Avenue

New York, NY 10022

 

Leerink Partners LLC

299 Park Avenue, 21st Floor

New York, NY 10171

 

June 26, 2017

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-7010

 

Attn:                    Ms. Suzanne Hayes

Ms. Christine Westbrook

Ms. Bonnie Baynes

Ms. Angela Connell

 

Re:                             Dova Pharmaceuticals, Inc.

Registration Statement on Form S-1

Registration File No. 333-218479

 

Ladies and Gentlemen:

 

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as underwriters, hereby join in the request of Dova Pharmaceuticals, Inc. (the “Company”) for acceleration of the effective date of the above-named Registration Statement on Form S-1, as amended, so that it becomes effective at 4:00 PM, Eastern Daylight Time, on June 28, 2017 or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Cooley LLP, may orally request via telephone call that such Registration Statement be declared effective.

 

Pursuant to Rule 460 under the Act, we, as underwriters, wish to advise you that approximately 2,444 copies of the Preliminary Prospectus, dated June 19, 2017 and included in the above-named Registration Statement, as amended, were distributed during the period from June 19, 2017 through the date hereof, to prospective underwriters, institutions, dealers and others.

 

We, the undersigned, as underwriters, will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 


 

 

Very truly yours,

 

 

 

J.P. MORGAN SECURITIES LLC
JEFFERIES LLC
LEERINK PARTNERS LLC

 

 

 

 

By:

J.P. MORGAN SECURITIES LLC

 

 

 

 

 

 

 

By:

/s/ David Ke

 

 

Name: David Ke

 

 

Title: Vice President

 

 

 

 

 

 

 

By:

JEFFERIES LLC

 

 

 

 

 

 

 

By:

/s/ Matthew Kim

 

 

Name: Matthew Kim

 

 

Title: Managing Director

 

 

 

 

 

 

 

By:

LEERINK PARTNERS LLC

 

 

 

 

 

 

 

By:

/s/ Anthony Gibney

 

 

Name: Anthony Gibney

 

 

Title: Managing Director